SIRT1 deacetylation of mutant huntingtin prevents its degradation, thus inhibition of SIRT1 could be beneficial for patients suffering from Huntington’s Disease (HD) (Dai et al., 2018; Fiorentino et al., 2022). Here, HTT is linked to Huntington disease.